RecruitingNCT04748770

Access to Kidney Transplant of Obese Patients Beginning Dialysis

Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

100 participants

Start Date

Jan 11, 2021

Study Type

OBSERVATIONAL

Conditions

Obese Patients Comorbidities Dialysis Kidney Transplant Access

Summary

Obesity is in constant increase all over the world and affects 35% of the global population according to the World Health Organisation. It is associated with other cardiovascular risk factors (particularly hypertension and diabetes) and with high morbi-mortality. It is also responsible for an increase of the risk of developing chronic kidney diseases (CKD). In fact, obese patients represent 25% of the dialysis population and Picardy is one of the most affected areas. However, their access to kidney transplant is still restricted and the reasons are not completely understood.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with comorbidities, dialysis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.